StockData
Alnylam Pharmaceuticals, Inc. logo

Alnylam Pharmaceuticals, Inc. (ALNY) stock

ALNYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3047% below fair value
$149.40−7.10 (-4.54%)

Close on Nov 18, 2026Market cap $20.01BP/E 7.8Yield –

Alnylam Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Alnylam Pharmaceuticals's market cap was $21.38B on Nov 11, 2026, against $59.47B a year earlier. Over the last 5 years it ranged from $15.19B to $59.73B, with a median of $27.43B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$21.38B-59.2%
2025Dec 31, 2025$52.41B+72.9%
2024Dec 31, 2024$30.32B+26.3%
2023Dec 29, 2023$24.01B-17.8%
2022Dec 30, 2022$29.23B+44.3%
2021Dec 31, 2021$20.26B+34.2%
2020Dec 31, 2020$15.10B+17.7%
2019Dec 31, 2019$12.82B+74.2%
2018Dec 31, 2018$7.36B-37.3%
2017Dec 29, 2017$11.74B+265.5%
2016Dec 30, 2016$3.21B-59.7%
2015Dec 31, 2015$7.97B+7.2%
2014Dec 31, 2014$7.44B+82.9%
2013Dec 31, 2013$4.07B+325.4%
2012Dec 31, 2012$955.91M+174.8%
2011Dec 30, 2011$347.91M-16.3%
2010Dec 31, 2010$415.70M–

More Alnylam Pharmaceuticals figures

See a number that looks wrong?